Tepotinib trials for Lung cancer

All Tepotinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Tepotinib for Lung cancer

• A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
  NCT07619339 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
  NCT06106802 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
  NCT06031688 · Phase: Phase 2 · Ages: 18 Minutes and older · Sex: All (male and female) · 266 locations
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
  NCT06908993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 29 locations

Common questions

How many trials study Tepotinib for Lung cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.